Stock comparison
Celcuity Inc. is 1.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($5.25 B vs $4.80 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
CELC is larger
Celcuity Inc. is 1.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($5.25 B vs $4.80 B).
Market value leader
CELC
Celcuity Inc. is 1.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($5.25 B vs $4.80 B).
Profit leader
CAI
CAI: -$68.09M vs CELC: -$177.04M.
| Metric | CAI | CELC |
|---|---|---|
| Market cap | $4.80 B | $5.25 B |
| US-listed rank | #1449 | #1384 |
| Revenue (latest FY) | $812.03M | - |
| Net income (latest FY) | -$68.09M | -$177.04M |
| Net margin | -8.4% | - |
| P/E (trailing FY) | - | - |
| SEC filings | 102 | 506 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Celcuity Inc. is 1.1x more valuable than Caris Life Sciences, Inc. by market capitalization ($5.25 B vs $4.80 B).
Full pages: Caris Life Sciences, Inc. and Celcuity Inc., or browse the full rankings.